UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Enhancing Outpatient Symptom Management in Patients With Head and Neck Cancer: A Qualitative Analysis

JAMA otolaryngology-- head & neck surgery, 2022-04, Vol.148 (4), p.333

2022

Volltextzugriff (PDF)

Should Basket Trials Be Pathways to Drug Registration for Biomarker-Defined Subgroups of Advanced Cancers?

Journal of clinical oncology, 2021-08, Vol.39 (22), p.JCO2100552-2429

2021

Volltextzugriff (PDF)

Fracture risk among patients with cancer compared to individuals without cancer: a population-based study

British journal of cancer, 2023-09, Vol.129 (4), p.665-671

2023

Volltextzugriff (PDF)

Poor recognition of risk factors for hepatitis B by physicians prescribing immunosuppressive therapy: a call for universal rather than risk-based screening

PloS one, 2015-04, Vol.10 (4), p.e0120749-e0120749

2015

Volltextzugriff (PDF)

Do female and male patients derive similar benefits from approved systemic oncology therapies? A systematic review and meta-analysis

Journal of cancer research and clinical oncology, 2023-07, Vol.149 (8), p.4215-4224

2023

Volltextzugriff (PDF)

Efficacy and safety of palonosetron for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV): a systematic review and meta-analysis of randomized controlled trials

Supportive care in cancer, 2014-06, Vol.22 (6), p.1685-1697

2014

Volltextzugriff (PDF)

Changes in Health Care Costs, Survival, and Time Toxicity in the Era of Immunotherapy and Targeted Systemic Therapy for Melanoma

JAMA dermatology (Chicago, Ill.), 2023-11, Vol.159 (11), p.1195

2023

Volltextzugriff (PDF)

Comparison of outcomes in a population-based cohort of metastatic breast cancer patients receiving anti-HER2 therapy with clinical trial outcomes

Breast cancer research and treatment, 2020-05, Vol.181 (1), p.155-165

2020

Volltextzugriff (PDF)

Cancer treatment-related financial toxicity experienced by patients in low- and middle-income countries: a scoping review

Supportive care in cancer, 2022-08, Vol.30 (8), p.6463-6471

2022

Volltextzugriff (PDF)

Power and sample size calculation for incremental net benefit in cost effectiveness analyses with applications to trials conducted by the Canadian Cancer Trials Group

BMC medical research methodology, 2023-08, Vol.23 (1), p.179-179, Article 179

2023

Volltextzugriff (PDF)

Neoadjuvant treatments for locally advanced, resectable esophageal cancer: A network meta‐analysis

International journal of cancer, 2018-07, Vol.143 (2), p.430-437

2018

Volltextzugriff (PDF)

Cost-effectiveness analysis of treatment with non-curative or palliative intent for hepatocellular carcinoma in the real-world setting

PloS one, 2017-10, Vol.12 (10), p.e0185198-e0185198

2017

Volltextzugriff (PDF)

Phase-specific and lifetime costs of cancer care in Ontario, Canada

BMC cancer, 2016-10, Vol.16 (1), p.809-809, Article 809

2016

Volltextzugriff (PDF)

Cost-effectiveness analysis of first-line treatment with crizotinib in ROS1-rearranged advanced non-small cell lung cancer (NSCLC) in Canada

BMC cancer, 2021-10, Vol.21 (1), p.1162-1162, Article 1162

2021

Volltextzugriff (PDF)

Economic analysis of osimertinib in previously untreated EGFR-mutant advanced non-small cell lung cancer in Canada

Lung cancer (Amsterdam, Netherlands), 2018-11, Vol.125, p.1-7

2018

Volltextzugriff (PDF)

DC-SIGN and L-SIGN: the SIGNs for infection

Journal of molecular medicine (Berlin, Germany), 2008-08, Vol.86 (8), p.861-874

2008

Volltextzugriff (PDF)

Assessing the efficacy‐effectiveness gap for cancer therapies: A comparison of overall survival and toxicity between clinical trial and population‐based, real‐world data for contemporary parenteral cancer therapeutics

Cancer, 2020-04, Vol.126 (8), p.1717-1726

2020

Volltextzugriff (PDF)

Health technology assessment methodology in metastatic renal cell carcinoma

Nature reviews. Urology, 2020-01, Vol.17 (1), p.3-5

2020

Volltextzugriff (PDF)

Estimating hazard ratios from published Kaplan‐Meier survival curves: A methods validation study

Research synthesis methods, 2019-09, Vol.10 (3), p.465-475

2019

Volltextzugriff (PDF)

Impact of limited sample size and follow-up on single event survival extrapolation for health technology assessment: a simulation study

BMC medical research methodology, 2021-12, Vol.21 (1), p.282-12, Article 282

2021

Volltextzugriff (PDF)

Association of Neurocognitive Deficits With Radiotherapy or Chemoradiotherapy for Patients With Head and Neck Cancer

JAMA otolaryngology-- head & neck surgery, 2018-01

2018

Volltextzugriff (PDF)

Comparative Effectiveness and Safety of Trastuzumab Biosimilars to Herceptin for Adjuvant Treatment of HER2+ Breast Cancer

Current oncology (Toronto), 2024-03, Vol.31 (3), p.1633-1644

2024

Volltextzugriff (PDF)

Sex-Based Analysis of Quality Indicators of End-of-Life Care in Gastrointestinal Malignancies

Current oncology (Toronto), 2024-02, Vol.31 (3), p.1170-1182

2024

Volltextzugriff (PDF)

Longitudinal assessment of right ventricular structure and function by cardiovascular magnetic resonance in breast cancer patients treated with trastuzumab: a prospective observational study

Journal of cardiovascular magnetic resonance, 2017-04, Vol.19 (1), p.44-9, Article 44

2017

Volltextzugriff (PDF)

Impact of body mass index on survival in women receiving chemotherapy for early breast cancer

Breast cancer research and treatment, 2022-11, Vol.196 (2), p.329-339

2022

Volltextzugriff (PDF)

1 – 25 von 1.089

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.015)
Mit Volltextzugriff
(950)

Publikationsform

Sprache

Englisch
(1.085)
Chinesisch
(4)
Japanisch
(2)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(115)
Current Oncology
(27)
Plos One
(22)
Gastroenterology
(19)
Alzheimer's & Dementia
(17)
Blood
(16)
Cancer
(16)
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi
(16)
Cancer Medicine
(13)
Jama Network Open
(12)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Enhancing Outpatient Symptom Management in Patients With Head and Neck Cancer: A Qualitative Analysis

Should Basket Trials Be Pathways to Drug Registration for Biomarker-Defined Subgroups of Advanced Cancers?

Fracture risk among patients with cancer compared to individuals without cancer: a population-based study

Poor recognition of risk factors for hepatitis B by physicians prescribing immunosuppressive therapy: a call for universal rather than risk-based screening

Do female and male patients derive similar benefits from approved systemic oncology therapies? A systematic review and meta-analysis

Efficacy and safety of palonosetron for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV): a systematic review and meta-analysis of randomized controlled trials

Changes in Health Care Costs, Survival, and Time Toxicity in the Era of Immunotherapy and Targeted Systemic Therapy for Melanoma

Comparison of outcomes in a population-based cohort of metastatic breast cancer patients receiving anti-HER2 therapy with clinical trial outcomes

Cancer treatment-related financial toxicity experienced by patients in low- and middle-income countries: a scoping review

Power and sample size calculation for incremental net benefit in cost effectiveness analyses with applications to trials conducted by the Canadian Cancer Trials Group

Neoadjuvant treatments for locally advanced, resectable esophageal cancer: A network meta‐analysis

Cost-effectiveness analysis of treatment with non-curative or palliative intent for hepatocellular carcinoma in the real-world setting

Phase-specific and lifetime costs of cancer care in Ontario, Canada

Cost-effectiveness analysis of first-line treatment with crizotinib in ROS1-rearranged advanced non-small cell lung cancer (NSCLC) in Canada

Economic analysis of osimertinib in previously untreated EGFR-mutant advanced non-small cell lung cancer in Canada

DC-SIGN and L-SIGN: the SIGNs for infection

Assessing the efficacy‐effectiveness gap for cancer therapies: A comparison of overall survival and toxicity between clinical trial and population‐based, real‐world data for contemporary parenteral cancer therapeutics

Health technology assessment methodology in metastatic renal cell carcinoma

Estimating hazard ratios from published Kaplan‐Meier survival curves: A methods validation study

Impact of limited sample size and follow-up on single event survival extrapolation for health technology assessment: a simulation study

Association of Neurocognitive Deficits With Radiotherapy or Chemoradiotherapy for Patients With Head and Neck Cancer

Comparative Effectiveness and Safety of Trastuzumab Biosimilars to Herceptin for Adjuvant Treatment of HER2+ Breast Cancer

Sex-Based Analysis of Quality Indicators of End-of-Life Care in Gastrointestinal Malignancies

Longitudinal assessment of right ventricular structure and function by cardiovascular magnetic resonance in breast cancer patients treated with trastuzumab: a prospective observational study

Impact of body mass index on survival in women receiving chemotherapy for early breast cancer

Suchergebnisse filtern